Prognostic Impacts of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome Patients Without Heart Failure

• Main Authors: Runzhen Chen (Author), Chen Liu (Author), Peng Zhou (Author), Jiannan Li (Author), Jinying Zhou (Author), Ying Wang (Author), Xiaoxiao Zhao (Author), Yi Chen (Author), Shaodi Yan (Author), Li Song (Author), Hanjun Zhao (Author), Hongbing Yan (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Despite the recommendations from mainstream guidelines, the use of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) for acute coronary syndrome (ACS) patients without heart failure (HF) is controversial, as its evidence is lacking in the era of repe...